脑转移瘤相关性癫痫的研究进展

doi:10.19854/j.cnki.1008-2425.2022.06.0012

摘要/Abstract

摘要： 脑转移瘤(brain metastases,BM)是成人中常见的继发性脑部病变,约有20%-40%的癌症患者在疾病发展的过程中发生脑转移,BM常预示着癌症发展到了晚期,患者主要的临床症状包括头痛、癫痫发作以及神经系统功能缺陷如运动或语言障碍,癫痫发作有时甚至是首发的临床症状。BM患者在接受手术、放疗或化疗后,身体可能已经很虚弱,而癫痫发作将对患者的生活质量以及对肿瘤治疗后的康复产生重大影响,从而给家属对患者的照顾提出了更大的挑战。随着BM和其他原位肿瘤的治疗进展,BM患者的生存周期延长,其癫痫的发生率也将随之升高。本文将对BM相关性癫痫(brain metastases related epilepsy,BMRE)的治疗研究进展做一综述。

关键词: 脑转移瘤, 肺癌, 癫痫, 研究进展

中图分类号:

R742.1

庞丛, 马炜. 脑转移瘤相关性癫痫的研究进展[J]. 立体定向和功能性神经外科杂志, 2022, 35(6): 377-381.

参考文献

[1] Davis FG,Dolecek TA,Mccarthy BJ,et al.Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data[J].Neuro Oncol,2012,14(9):1171~1177.
[2] Smedby KE,Brandt L,Backlund ML,et al.Brain metastases admissions in Sweden between 1987 and 2006[J].Br J Cancer,2009,101(11):1919~1924.
[3] Soffietti R,Cornu P,Delattre JY,et al.EFNS Guidelines on diagnosis and treatment of brain metastases:report of an EFNS Task Force[J].Eur J Neurol,2006,13(7):674~681.
[4] Yamanaka R,Koga H,Yamamoto Y,et al.Characteristics of patients with brain metastases from lung cancer in a palliative care center.[J].Supportive care in cancer:official journal of the Multinational Association of Supportive Care in Cancer,2011,19(4).
[5] Stelzer KJ.Epidemiology and prognosis of brain metastases[J].Surg Neurol Int,2013,4(Suppl 4):S192~S202.
[6] Weller M,Stupp R,Wick W.Epilepsy meets cancer:when,why,and what to do about it?[J].Lancet Oncol,2012,13(9):e375~e382.
[7] Singh G,Rees J H,Sander J W.Seizures and epilepsy in oncological practice:causes,course,mechanisms and treatment[J].J Neurol Neurosurg Psychiatry,2007,78(4):342~349.
[8] 胡英春,孙作斌.以癫痫为首发症状的肺癌脑转移21例临床分析[J].癌症进展,2009,7(5):574~576.
[9] Oberndorfer S,Schmal T,Lahrmann H,et al.[The frequency of seizures in patients with primary brain tumors or cerebral metastases.An evaluation from the Ludwig Boltzmann Institute of Neuro-Oncology and the Department of Neurology,Kaiser Franz Josef Hospital,Vienna] [J].Wien Klin Wochenschr,2002,114(21-22):911~916.
[10] Chan V,Sahgal A,Egeto P,et al.Incidence of seizure in adult patients with intracranial metastatic disease[J].J Neurooncol,2017,131(3):619~624.
[11] Wolpert F,Lareida A,Terziev R,et al.Risk factors for the development of epilepsy in patients with brain metastases[J].Neuro Oncol,2020,22(5):718~728.
[12] Skardelly M,Brendle E,Noell S,et al.Predictors of preoperative and early postoperative seizures in patients with intra-axial primary and metastatic brain tumors:A retrospective observational single center study[J].Ann Neurol,2015,78(6):917~928.
[13] Wu A,Weingart J D,Gallia G L,et al.Risk Factors for Preoperative Seizures and Loss of Seizure Control in Patients Undergoing Surgery for Metastatic Brain Tumors[J].World Neurosurg,2017,104:120~128.
[14] Ruda R,Mo F,Pellerino A.Epilepsy in brain metastasis:an emerging entity[J].Curr Treat Options Neurol,2020,22(2):6.
[15] Goldlust S A,Hsu M,Lassman A B,et al.Seizure prophylaxis and melanoma brain metastases[J].J Neurooncol,2012,108(1):109~114.
[16] Lee M H,Kong D S,Seol H J,et al.Risk of seizure and its clinical implication in the patients with cerebral metastasis from lung cancer[J].Acta Neurochir(Wien),2013,155(10):1833~1837.
[17] Cohen Z R,Suki D,Weinberg J S,et al.Brain metastases in patients with ovarian carcinoma:prognostic factors and outcome[J].J Neurooncol,2004,66(3):313~325.
[18] Borella F,Bertero L,Morrone A,et al.Brain Metastases from Ovarian Cancer:Current Evidence in Diagnosis,Treatment,and Prognosis[J].Cancers(Basel),2020,12(8).
[19] Tremont-Lukats I W,Bobustuc G,Lagos G K,et al.Brain metastasis from prostate carcinoma:The M.D.Anderson Cancer Center experience[J].Cancer,2003,98(2):363~368.
[20] Asano K,Hasegawa S,Matsuzaka M,et al.Brain tumor-related epilepsy and risk factors for metastatic brain tumors:analysis of 601 consecutive cases providing real-world data[J].J Neurosurg,2022,136(1):76~87.
[21] Maschio M,Dinapoli L,Gomellini S,et al.Antiepileptics in brain metastases:safety,efficacy and impact on life expectancy[J].J Neurooncol,2010,98(1):109~116.
[22] Bahna M,Heimann M,Bode C,et al.Tumor-associated epilepsy in patients with brain metastases:necrosis-to-tumor ratio forecasts postoperative seizure freedom[J].Neurosurg Rev,2022,45(1):545~551.
[23] Fox J,Ajinkya S,Greenblatt A,et al.Clinical characteristics,EEG findings and implications of status epilepticus in patients with brain metastases[J].J Neurol Sci,2019,407:116538.
[24] You G,Sha Z,Jiang T.The pathogenesis of tumor-related epilepsy and its implications for clinical treatment[J].Seizure,2012,21(3):153~159.
[25] Chen D Y,Chen C C,Crawford J R,et al.Tumor-related epilepsy:epidemiology,pathogenesis and management[J].J Neurooncol,2018,139(1):13~21.
[26] Soffietti R,Abacioglu U,Baumert B,et al.Diagnosis and treatment of brain metastases from solid tumors:guidelines from the European Association of Neuro-Oncology(EANO)[J].Neuro Oncol,2017,19(2):162~174.
[27] Chen CC,Rennert RC,Olson JJ.Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Role of Prophylactic Anticonvulsants in the Treatment of Adults with Metastatic Brain Tumors[J].Neurosurgery,2019,84(3):E195~E197.
[28] 中国医师协会肿瘤医师分会,中国医疗保健国际交流促进会肿瘤内科分会.肺癌脑转移中国治疗指南(2021年版)[J].中华肿瘤杂志,2021,43(3):269~281.
[29] Glauser T,Ben-Menachem E,Bourgeois B,et al.Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.[J].Epilepsia,2013,54(3).
[30] Newton HB,Dalton J,Goldlust S,et al.Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors.[J].Journal of neuro-oncology,2007,84(3).
[31] Benit CP,Vecht CJ.Seizures and cancer:drug interactions of anticonvulsants with chemotherapeutic agents,tyrosine kinase inhibitors and glucocorticoids[J].Neurooncol Pract,2016,3(4):245~260.
[32] Reddy JP,Dawood S,Mitchell M,et al.Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy[J].Radiother Oncol,2015,117(2):308~314.
[33] Cacho-Diaz B,San-Juan D,Salmeron K,et al.Choice of antiepileptic drugs affects the outcome in cancer patients with seizures[J].Clin Transl Oncol,2018,20(12):1571~1576.
[34] Puri PR,Johannsson B,Seyedi JF,et al.The risk of developing seizures before and after surgery for brain metastases[J].Clin Neurol Neurosurg,2020,193:105779.
[35] Garcia JH,Morshed RA,Chung J,et al.Factors associated with preoperative and postoperative seizures in patients undergoing resection of brain metastases[J].J Neurosurg,2022:1~8.
[36] Wong J,Hird A,Zhang L,et al.Symptoms and quality of life in cancer patients with brain metastases following palliative radiotherapy[J].Int J Radiat Oncol Biol Phys,2009,75(4):1125~1131.
[37] Julie D,Ahmed Z,Karceski SC,et al.An overview of anti-epileptic therapy management of patients with malignant tumors of the brain undergoing radiation therapy[J].Seizure,2019,70:30~37.
[38] Carpentier A,Mcnichols RJ,Stafford RJ,et al.Real-time magnetic resonance-guided laser thermal therapy for focal metastatic brain tumors[J].Neurosurgery,2008,63(1 Suppl 1):S21-S28,S28~S29.
[39] Riviere-Cazaux C,Bhandarkar A R,Rahman M,et al.Outcomes and principles of patient selection for laser interstitial thermal therapy(LITT) for metastatic brain tumor management:a multi-site,institutional case series[J].World Neurosurg,2022.
[40] Bastos D,Fuentes DT,Traylor J,et al.The use of laser interstitial thermal therapy in the treatment of brain metastases:a literature review[J].Int J Hyperthermia,2020,37(2):53~60.
[41] Salehi A,Kamath AA,Leuthardt EC,et al.Management of intracranial metastatic disease with laser interstitial thermal therapy[J].Front Oncol,2018,8:499.